Cargando…

Metabolomic Profiles Are Gender, Disease and Time Specific in the Interleukin-10 Gene-Deficient Mouse Model of Inflammatory Bowel Disease

Metabolomic profiling can be used to study disease-induced changes in inflammatory bowel diseases (IBD). The aim of this study was to investigate the difference in the metabolomic profile of males and females as they developed IBD. Using the IL-10 gene-deficient mouse model of IBD and wild-type mice...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tso, Victor K., Sydora, Beate C., Foshaug, Rae R., Churchill, Thomas A., Doyle, Jason, Slupsky, Carolyn M., Fedorak, Richard N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706546/ https://www.ncbi.nlm.nih.gov/pubmed/23874435 http://dx.doi.org/10.1371/journal.pone.0067654

Ejemplares similares

Urine metabolomics as a predictor of patient tolerance and response to adjuvant chemotherapy in colorectal cancer
por: Dykstra, Mark A., et al.
Publicado: (2017)

Development and Validation of a High-Throughput Mass Spectrometry Based Urine Metabolomic Test for the Detection of Colonic Adenomatous Polyps
por: Deng, Lu, et al.
Publicado: (2017)

A Machine-Learned Predictor of Colonic Polyps Based on Urinary Metabolomics
por: Eisner, Roman, et al.
Publicado: (2013)

Interleukin 10 and interleukin 10 receptor in paediatric inflammatory bowel disease: from bench to bedside lesson
por: Krawiec, Paulina, et al.
Publicado: (2021)

Long-term outcomes after enterostomy for very early-onset inflammatory bowel disease with interleukin-10 signaling deficiency
por: Tang, Zifei, et al.
Publicado: (2023)

Patients with Inflammatory Bowel Disease Exhibit Dysregulated Responses to Microbial DNA
por: Hotte, Naomi S. C., et al.
Publicado: (2012)

Role of Serum Interleukin-6, Interleukin-1β and Interleukin-10 in Assessment of Disease Activity and Nutritional Status in Patients with Inflammatory Bowel Disease
por: Godala, Małgorzata, et al.
Publicado: (2023)

Don’t Forget the Doctor: Gastroenterologists’ Preferences on the Development of mHealth Tools for Inflammatory Bowel Disease
por: van Mierlo, Trevor, et al.
Publicado: (2015)

Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease
por: Wilke, Cailin M, et al.
Publicado: (2011)

Alterations of Colonic Contractility in an Interleukin-10 Knockout Mouse Model of Inflammatory Bowel Disease
por: Park, Jae Hyung, et al.
Publicado: (2015)

Investigation of Interleukin-10 Promoter Polymorphisms and Interleukin-10 Levels in Children with Irritable Bowel Syndrome
por: Hua, Man-Chin, et al.
Publicado: (2013)

Systematic Review: Non-medical Switching of Infliximab to CT-P13 in Inflammatory Bowel Disease
por: Bernard, Edmond-Jean, et al.
Publicado: (2020)

Microbiome, Metabolome and Inflammatory Bowel Disease
por: Ahmed, Ishfaq, et al.
Publicado: (2016)

Interleukin-10 in the Pathophysiology of Inflammatory Bowel Disease: Increased Serum Concentrations During the Recovery Phase
por: Mitsuyama, Keiichi, et al.
Publicado: (2006)

Frequency of CD4+CD161+ T Cell and Interleukin-10 Expression in Inflammatory Bowel Diseases
por: Tsuchiya, Kazuyo, et al.
Publicado: (2017)

Genetic association and epistatic interaction of the interleukin-10 signaling pathway in pediatric inflammatory bowel disease
por: Lin, Zhenwu, et al.
Publicado: (2017)

Metabolomic profiling to characterize acute intestinal ischemia/reperfusion injury
por: Khadaroo, Rachel G., et al.
Publicado: (2017)

Metabolomics analysis of children with autism, idiopathic-developmental delays, and Down syndrome
por: Orozco, Jennie Sotelo, et al.
Publicado: (2019)

Effects of iron supplementation on growth, gut microbiota, metabolomics and cognitive development of rat pups
por: Alexeev, Erica E., et al.
Publicado: (2017)

Indigenous gender and wellness: a scoping review of Canadian research
por: Tremblay, Melissa, et al.
Publicado: (2023)

Metabolomic changes in severe acute malnutrition suggest hepatic oxidative stress: a secondary analysis
por: Parenti, Mariana, et al.
Publicado: (2021)

Interleukin-17 and Interleukin-10 Association with Disease Progression in Schizophrenia
por: Chenniappan, Raghavi, et al.
Publicado: (2020)

Expression of Interleukin-26 is upregulated in inflammatory bowel disease
por: Fujii, Makoto, et al.
Publicado: (2017)

A Comparison of Serum and Plasma Blood Collection Tubes for the Integration of Epidemiological and Metabolomics Data
por: Sotelo-Orozco, Jennie, et al.
Publicado: (2021)

Complications of enterostomy and related risk factor analysis of very early onset inflammatory bowel disease with interleukin-10 signalling deficiency: a single-centre retrospective analysis
por: Tang, Zifei, et al.
Publicado: (2020)

Impact of milk secretor status on the fecal metabolome and microbiota of breastfed infants
por: Wang, Aidong, et al.
Publicado: (2023)

Development and Validation of a Highly Sensitive Urine-Based Test to Identify Patients with Colonic Adenomatous Polyps
por: Wang, Haili, et al.
Publicado: (2014)

Management of Inflammatory Bowel Disease Patients With Clinical Care Pathways Reduces Emergency Department Utilization
por: Lytvyak, Ellina, et al.
Publicado: (2020)

Effect of the interleukin 10 polymorphisms on interleukin 10 production and visceral hypersensitivity in Chinese patients with diarrhea-predominant irritable bowel syndrome
por: Zhu, Shi-Wei, et al.
Publicado: (2019)

Metabolomics facilitate the personalized management in inflammatory bowel disease
por: Chen, Rirong, et al.
Publicado: (2021)

Faecal metabolome and its determinants in inflammatory bowel disease
por: Vich Vila, Arnau, et al.
Publicado: (2023)

Serum interleukin 17A and interleukin 17F in children with inflammatory bowel disease
por: Krawiec, Paulina, et al.
Publicado: (2020)

Assessing young adults' menopause knowledge to increase understanding of symptoms and help improve quality of life for women going through menopause; a student survey
por: Patel, Vaishvi, et al.
Publicado: (2023)

Interleukin – 17 and Interleukin-10 as Inflammatory and Prevention Biomarkers in Periimplant Diseases
por: Farhad, Shirin Zahra, et al.
Publicado: (2019)

Interleukin-24 regulates mucosal remodeling in inflammatory bowel diseases
por: Ónody, Anna, et al.
Publicado: (2021)

T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice
Publicado: (1995)

Interleukin-10 deficiency exacerbates inflammation-induced tau pathology
por: Weston, Lea L., et al.
Publicado: (2021)

Effect of bovine milk fat globule membranes as a complementary food on the serum metabolome and immune markers of 6-11-month-old Peruvian infants
por: Lee, Hanna, et al.
Publicado: (2018)

Metabolomics Insights into Inflammatory Bowel Disease: A Comprehensive Review
por: Aldars-García, Laila, et al.
Publicado: (2021)

The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease
por: Xu, Xinwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oijc42f0ao1577l8tj5ssh9r1j